DENTSPLY SIRONA (NASDAQ:XRAY) Lowered to “Hold” Rating by StockNews.com

StockNews.com downgraded shares of DENTSPLY SIRONA (NASDAQ:XRAY) from a buy rating to a hold rating in a research note issued to investors on Tuesday.

XRAY has been the topic of several other research reports. Leerink Partners lowered DENTSPLY SIRONA from an “outperform” rating to a “market perform” rating in a report on Thursday, November 7th. Robert W. Baird cut their target price on DENTSPLY SIRONA from $31.00 to $24.00 and set a “neutral” rating on the stock in a research report on Friday, November 8th. Evercore ISI lowered their price target on DENTSPLY SIRONA from $29.00 to $27.00 and set an “outperform” rating for the company in a report on Tuesday, October 8th. Leerink Partnrs cut shares of DENTSPLY SIRONA from a “strong-buy” rating to a “hold” rating in a report on Thursday, November 7th. Finally, Needham & Company LLC lowered their target price on shares of DENTSPLY SIRONA from $34.00 to $29.00 and set a “buy” rating for the company in a report on Friday, October 25th. Seven research analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Hold” and an average target price of $29.50.

DENTSPLY SIRONA Price Performance

XRAY stock opened at $18.88 on Tuesday. The business’s 50-day moving average is $23.66 and its two-hundred day moving average is $25.25. The company has a debt-to-equity ratio of 0.72, a current ratio of 1.25 and a quick ratio of 0.84. The firm has a market capitalization of $3.75 billion, a P/E ratio of -9.12, a P/E/G ratio of 1.80 and a beta of 1.02. DENTSPLY SIRONA has a 1 year low of $17.21 and a 1 year high of $37.60.

DENTSPLY SIRONA (NASDAQ:XRAY) last issued its earnings results on Thursday, November 7th. The medical instruments supplier reported $0.50 earnings per share for the quarter, beating the consensus estimate of $0.48 by $0.02. DENTSPLY SIRONA had a negative net margin of 10.59% and a positive return on equity of 12.62%. The firm had revenue of $951.00 million for the quarter, compared to analysts’ expectations of $939.10 million. During the same quarter last year, the company earned $0.49 earnings per share. The firm’s revenue was up .4% compared to the same quarter last year. Analysts anticipate that DENTSPLY SIRONA will post 1.84 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

A number of institutional investors have recently bought and sold shares of the business. First Eagle Investment Management LLC grew its holdings in shares of DENTSPLY SIRONA by 33.6% during the second quarter. First Eagle Investment Management LLC now owns 13,069,900 shares of the medical instruments supplier’s stock worth $325,571,000 after buying an additional 3,283,965 shares during the last quarter. Nuance Investments LLC grew its stake in shares of DENTSPLY SIRONA by 3.8% in the 2nd quarter. Nuance Investments LLC now owns 10,879,916 shares of the medical instruments supplier’s stock valued at $271,019,000 after purchasing an additional 402,329 shares during the last quarter. FMR LLC increased its holdings in shares of DENTSPLY SIRONA by 5.1% in the third quarter. FMR LLC now owns 9,056,774 shares of the medical instruments supplier’s stock valued at $245,076,000 after purchasing an additional 436,031 shares during the period. Cooke & Bieler LP raised its stake in shares of DENTSPLY SIRONA by 16.2% during the second quarter. Cooke & Bieler LP now owns 7,506,845 shares of the medical instruments supplier’s stock worth $186,996,000 after purchasing an additional 1,046,105 shares during the last quarter. Finally, Price T Rowe Associates Inc. MD lifted its holdings in shares of DENTSPLY SIRONA by 5.8% during the first quarter. Price T Rowe Associates Inc. MD now owns 6,266,781 shares of the medical instruments supplier’s stock worth $207,995,000 after purchasing an additional 343,915 shares during the period. 95.70% of the stock is currently owned by institutional investors and hedge funds.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.